1School of Physics and Technology,Wuhan University,Wuhan 430072,China; 2Department of Radiation Oncology,Zhongnan Hospital of Wuhan University,Wuhan 430071,China; 3Department of Radiation Oncology,Suizhou Central Hospital,Suizhou 441000,China
AbstractObjective To preliminarily verify the feasibility of utilizing TG119 report to commission the volumetric modulated arc therapy (VMAT) plans. Methods Based on the test cases mentioned in TG119 report,7-/9-field intensity-modulated radiation therapy (IMRT) and dual-arc VMAT plans were devised by using two types of beam energy (6 MV and 10 MV) in the Eclipse TPS system according to the requirement of this report. All the plans were verified using 0.125cc semiflex thimble ionization chamber,MatriXX and Delta 4,respectively. The final results were statistically compared with the results measured by multiple institutions in the TG119 report. Results The results of both IMRT and VMAT plans met the requirement of the TG119 report. The discrepancy of point dose in the high/low dose region of VMAT plans using different photon beams was ranged from -2.55% to 2.55%,and ±1.85% for the IMRT plans. The percentage of γ passing points (±3%/3 mm) for the IMRT plans using 6 MV and 10 MV photon beams was 99.38% and 99.53%,99.32% and 99.46% for the VMAT plans. The γ passing rate of the compound field exceeded 98%. Conclusions The VMAT plans with 6 MV and 10 MV photon beams meet the requirement of the TG119 report. TG119 report provides certain guidance for establishing a benchmark for dosimetry verification of the VMAT plans.
Corresponding Authors:
Quan Hong,Email:csp6606@sina.com
Cite this article:
Lyu Meng,Zhang Jun,Zhou Lixin et al. Preliminary study on dosimetry verification of VMAT on the basis of TG119 report[J]. Chinese Journal of Radiation Oncology, 2019, 28(3): 209-213.
Lyu Meng,Zhang Jun,Zhou Lixin et al. Preliminary study on dosimetry verification of VMAT on the basis of TG119 report[J]. Chinese Journal of Radiation Oncology, 2019, 28(3): 209-213.
[1] Zelefsky MJ,Fuks Z,Happersett L,et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer[J].Radiother Oncol J Eur Soc Ther Radiol Oncol,2000,55(3):241-249.DOI:10.1016/S0167-8140(99)00100-0. [2] Vieillot S,Fenoglietto P,Lemanski C,et al. IMRT for locally advanced anal cancer:clinical experience of the Montpellier Cancer Center[J].Radiat Oncol,2012,7(1):45. DOI:10.1186/1748-717X-7-45. [3] 吴式琇,张萍,谢聪颖,等.鼻咽癌调强放射治疗的临床研究[J].中华放射肿瘤学杂志,2004,13(3):154-157. Wu SX,Zhang P,Xie CY et al. Intensify modulated radiotherapy (IMRT) for nasopharyngeal carcinoma[J].Chin J Radiat Oncol,2004,13(3):154-157. [4] Otto K.Volumetric modulated arc therapy:IMRT in a single gantry arc.[J].Med Phys,2008,35(1):310-317.DOI:10.1118/1.2818738. [5] Kataria T,Govardhan HB,Gupta D,et al. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs. Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma[J].J Cancer Res Ther,2014,4(4):871-877. DOI:10.4103/0973-1482.138217. [6] Li J,Tang XB,Wang BH,et al. Comparison between Dual Arc VMAT and 7F-IMRT in the protection of hippocampus for patients during whole brain radiotherapy[J].J X-Ray Sci Technol,2016,24(3):457-466. DOI:10.3233/XST-160561. [7] Alexander AS,Wells D,Berrang T,et al. Volumetric Arc Therapy (VMAT) Reduces Treatment Time Compared to Conventional IMRT (cIMRT) While Maintaining Similar Plan Quality in Whole PelvicGynecologic Radiotherapy[J]. Int J Radiat Oncol Biol Phys,2008,72(1):S366-S366. DOI:10.1016/j.i jrobp.2008. 06.1203. [8] Ling CC,Zhang P,Archambault Y,et al. Commissioning and quality assurance of RapidArc radiotherapy delivery system.[J].Int J Radiat Oncol Biol Phys,2008,72(2):575. DOI:10.1016/j.ijrobp.2008.05.060. [9] Losasso T,Chui C,Ling CC.Comprehensive quality assurance for the delivery of intensity modulated radiotherapy with a multileaf collimator used in the dynamic mode[J]. Med Phys,2001,28(11):2209. DOI:10.1118/1.1410123. [10] Kim H,Lee H,Park JI,et al. Smartphone application for mechanical quality assurance of medical linear accelerator[J].Phys Med Biol,2017,62(11):N257-N270. DOI:10.1088/1361-6560/aa67 d5. [11] Barnes MP,Rowshanfarzad P,Greer PB.VMAT linear accelerator commissioning and quality assurance:dose control and gantry speed tests.[J].J Appl Clin Med Phys,2016,17(3):6067. DOI:10.1120/jacmp.v17i3.6067. [12] Mutic SPD,Todd P,Moderator OCG.EPID-based daily quality assurance of linear accelerators will likely replace other methods within the next ten years[J].Med Phys,2016,43(6):2691-2693. DOI:10.1118/1.4944423:. [13] Ezzell GA,Burmeister JW,Dogan N,et al. IMRT commissioning:Multiple institution planning and dosimetry comparisons,a report from AAPM Task Group 119[J].Med Phys,2009,36(11):5359-5373. DOI:10.1118/1.3238104. [14] Rao M,Yang W,Chen F,et al. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT:plan quality,delivery efficiency and accuracy[J].Med phys,2010,37(3):1350-1359.DOI:10.1118/1.3326965. [15] David P,Emily V,Kerry J,et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy:comparison with intensity-Modulated radiotherapy and three-dimensional conformal radiotherapy.[J].Int J Radiat Oncol Biol Phys,2008,72(4):996-1001.DOI:10.1016/j.ijrobp.2008.02.047. [16] Gordon JD,Krafft SP,Jang S,et al. Confidence limit variation for a single IMRT system following the TG119 protocol[J].Med Phys,2011,38(3):1641-1648.DOI:10.1118/1.3555298.
2019, Vol. 28 
